Epilog Partners is a private equity platform built by investors, operators and innovators for healthcare's complexity. It invests in tech-enabled payer, provider and pharma services companies that are improving clinical, financial, and experiential outcomes. Epilog targets equity investments of $50 to $200 million in leveraged buyouts of profitable, high-growth companies. Our partners have realized $11.5 billion in exits across eight companies over two decades as both investors and operators.

Health Care

Life Sciences

Venture Capital

Epilog Partners

Epilog Partners' headquarters in Boston, United States

Description

People (4)

Chris Price

Tim Petrikin

Kyle Gay

Craig Haratz

Jobs